The company has upgraded their home page and it looks so much more professional than before. Since they already have collaborations (partnerships) with three companies (including Merck and Stason) a partner for Bavi and Cotara should be close at hand. After looking at the updated home page, I think that Merck may be the most likely partner for the upcoming Phase III trials. All the reason to buy more shares at these cheap prices.
Market Data 
Markets 
AI
